All News

Eli Lilly is extending its push in neuroscience while the FDA wrestles with controversial peptide drugs. …

Novo is seeking an injunction that would halt allegedly "misleading" obesity drug ads. Elsewhere, the FDA bega…

An FDA advisory committee has recommended that four peptide drugs that were previously restricted because of p…

Sanofi has abandoned plans to seek approval for amlitelimab in atopic dermatitis, admitting that a drug once t…

Today's guest post comes from Chip Parkinson, CEO at Gifthealth. Chip discusses how Direct-to-Patient (DTP) mo…

The Trump administration released its blueprint for U.S. science, calling for shifting hundreds of billions of…

The startup is the first gene editing company to price an IPO in more than two years, though it banked far les…

A look at two recent CRLs demonstrate the tension and discrepancies between how companies and the agency commu…

Boosting public trust, delivering genuine breakthroughs and getting trials off the ground remain top-of-mind i…

The former quarterback spoke with Fierce Pharma Marketing on teaming up with ARS, his journey with food allerg…

Australian biopharma Clinuvel Pharmaceuticals is moving its headquarters to the U.S.- but up to a fifth of the…

Mirroring the bipartisan bill introduced in the House, the measure would require a study from the GAO on the s…

Analysts expect new details on the lead-up to the deal "are likely to reignite" investor scrutiny that Vertex …

Multiple factors could get in the way of confirming a new commissioner before the midterm elections, experts s…

Amgen has agreed to a $74 million settlement with investors to resolve a lawsuit that alleged the company hid …

A rare disease startup with a mission to repurpose proven drugs has licensed a Chinese formulation of a well-k…

Science Corporation announced the European launch of its retinal implant for patients with age-related macular…

The study failure costs Agios a chance to one-up Novo Nordisk and represents yet another setback in a disease …

Lilly's neuroscience chief discusses the large pharma's aims in brain science, and how diagnostics and dosing …

Widespread misconceptions about Type 1 diabetes could be contributing to a reluctance to get screened for the …

Bristol Myers Squibb has entered into an expanded collaboration with Nvidia to create the biggest supercompute…